Literature DB >> 17312386

Linkage analysis of chromosome 4 in families with familial pancreatic cancer.

Alison P Klein1, Mariza de Andrade, Ralph H Hruban, Melissa Bondy, Ann G Schwartz, Steven Gallinger, Henry T Lynch, Sapna Syngal, Kari G Rabe, Michael G Goggins, Gloria M Petersen.   

Abstract

BACKGROUND: Approximately 10% of pancreatic ductal adenocarcinomas have a familial basis. While a small portion of this familial clustering can be explained by inherited mutations in known genes (BRCA2, p16/CDKN2A, PRSS1, and STK11), the genetic basis for the majority of this familial clustering remains unknown. In addition, a pancreatic cancer susceptibility locus has been reported to be linked to chromosome 4q32-34 in a single family having a high penetrance of early-onset pancreatic ductal adenocarcinoma and pancreatic insufficiency. The goal of this study is to determine if linkage to chromosome 4q exists in our series of well-characterized families with idiopathic familial pancreatic cancer enrolled in the Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE).
METHODS: Parametric and nonparametric linkage analyses were performed using 21 microsatellite markers on chromosome 4 on affected individuals with pancreatic cancer from 42 familial pancreatic cancer kindreds.
RESULTS: Markov Chain Monte Carlo parametric and nonparametric linkage analyses using SIMWALK2 as well as nonparametric linkage analysis using MERLIN did not provide strong evidence of linkage in this region (LOD < 1.0). Only one family provided a multipoint LOD score of >0.5 adjacent to the reported region.
CONCLUSIONS: Our results do not support linkage to the 4q32-34 region in the majority of our familial pancreatic cancer kindreds. However, because multiple pancreatic cancer susceptibility genes are likely to exist, it is possible that a subset of the families in this study may be linked to this region.

Entities:  

Mesh:

Year:  2007        PMID: 17312386      PMCID: PMC3144722          DOI: 10.4161/cbt.6.3.3721

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  26 in total

1.  Replication linkage study for prostate cancer susceptibility genes.

Authors:  B K Suarez; J Lin; J S Witte; D V Conti; M I Resnick; E A Klein; J K Burmester; D A Vaske; T K Banerjee; W J Catalona
Journal:  Prostate       Date:  2000-10-01       Impact factor: 4.104

2.  Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.

Authors:  Gonçalo R Abecasis; Stacey S Cherny; William O Cookson; Lon R Cardon
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

3.  Powerful allele sharing statistics for nonparametric linkage analysis.

Authors:  Ethan M Lange; Kenneth Lange
Journal:  Hum Hered       Date:  2004       Impact factor: 0.444

4.  Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.

Authors:  Noriyoshi Fukushima; Norihiro Sato; Takashi Ueki; Christophe Rosty; Kimberly M Walter; Robb E Wilentz; Charles J Yeo; Ralph H Hruban; Michael Goggins
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

5.  Evaluation of the 4q32-34 locus in European familial pancreatic cancer.

Authors:  Julie Earl; Li Yan; Louis J Vitone; Janet Risk; Steve J Kemp; Chris McFaul; John P Neoptolemos; William Greenhalf; Ralf Kress; Mercedes Sina-Frey; Stephan A Hahn; Harald Rieder; Detlef K Bartsch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-10       Impact factor: 4.254

6.  A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34.

Authors:  Michael A Eberle; Roland Pfützer; Kay L Pogue-Geile; Mary P Bronner; David Crispin; Michael B Kimmey; Richard H Duerr; Leonid Kruglyak; David C Whitcomb; Teresa A Brentnall
Journal:  Am J Hum Genet       Date:  2002-02-27       Impact factor: 11.025

7.  Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.

Authors:  Alison P Klein; Kieran A Brune; Gloria M Petersen; Michael Goggins; Anne C Tersmette; G Johan A Offerhaus; Constance Griffin; John L Cameron; Charles J Yeo; Scott Kern; Ralph H Hruban
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

8.  Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.

Authors:  Kathleen M Murphy; Kieran A Brune; Constance Griffin; Jennifer E Sollenberger; Gloria M Petersen; Ravi Bansal; Ralph H Hruban; Scott E Kern
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

9.  Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.

Authors:  Marcia Irene Canto; Michael Goggins; Charles J Yeo; Constance Griffin; Jennifer E Axilbund; Kieran Brune; Syed Z Ali; Sanjay Jagannath; Gloria M Petersen; Elliot K Fishman; Steven Piantadosi; Francis M Giardiello; Ralph H Hruban
Journal:  Clin Gastroenterol Hepatol       Date:  2004-07       Impact factor: 11.382

10.  BRCA2 germline mutations in familial pancreatic carcinoma.

Authors:  Stephan A Hahn; Bill Greenhalf; Ian Ellis; Mercedes Sina-Frey; Harald Rieder; Birgit Korte; Berthold Gerdes; Ralf Kress; Andreas Ziegler; John A Raeburn; Donata Campra; Robert Grützmann; Helga Rehder; Matthias Rothmund; Wolff Schmiegel; John P Neoptolemos; Detlef K Bartsch
Journal:  J Natl Cancer Inst       Date:  2003-02-05       Impact factor: 13.506

View more
  5 in total

Review 1.  Hereditary pancreatic cancer.

Authors:  Shilpa Grover; Sapna Syngal
Journal:  Gastroenterology       Date:  2010-08-19       Impact factor: 22.682

Review 2.  Pancreatic cancer screening.

Authors:  Eun Ji Shin; Marcia Irene Canto
Journal:  Gastroenterol Clin North Am       Date:  2012-01-05       Impact factor: 3.806

Review 3.  Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals.

Authors:  Hiroyuki Matsubayashi
Journal:  J Gastroenterol       Date:  2011-08-17       Impact factor: 7.527

Review 4.  Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.

Authors:  Andrew E Becker; Yasmin G Hernandez; Harold Frucht; Aimee L Lucas
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

5.  Absence of deleterious palladin mutations in patients with familial pancreatic cancer.

Authors:  Alison P Klein; Michael Borges; Margaret Griffith; Kieran Brune; Seung-Mo Hong; Noriyuki Omura; Ralph H Hruban; Michael Goggins
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.